There was a clear trend in the association between better tumor response and longer PFS and OS (Fig. 1 a, b).
← all excerpts
The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study.
1
—
—